The Food and Drug Administration Friday issued recommendations for health care providers to reduce the risk of adverse events associated with surgical staplers and staples for internal use. Among other recommendations, FDA recommends providers carefully follow the stapler manufacturer’s instructions for use, have a range of staple sizes available and select the appropriate size cartridge for the tissue. Since 2011, the agency has received more than 41,000 medical device reports for surgical staplers and staples for internal use, including 366 deaths. FDA plans this year to issue draft guidance to manufacturers on information to include in their product labeling and to hold a public meeting on whether to reclassify the staplers as Class II devices, which would allow the agency to establish mandatory special controls to mitigate known risks.

Related News Articles

Blog
Managing a crisis calls for strong leadership, a resilient workforce and reliable communication. Health care leaders across the country discussed crisis…
Headline
The AHA and the Federation of American Hospitals are urging Congress to oppose the Patient Access to Higher Quality Care Act (H.R. 977/S.470) and any other…
Headline
The Food and Drug Administration today released final guidance for transitioning medical device enforcement policies and emergency use authorizations…
Chairperson's File
The COVID-19 pandemic, opioid crisis and mpox outbreak. Hurricanes Ian and Fiona. Severe storms, flooding, landslides and mudslides in Kentucky. Wildfires and…
Perspective
“The vaccine for measles, mumps and rubella causes autism.” “The risk of taking a statin outweighs its benefit as a powerful tool to prevent heart attacks.” “…
Headline
Age-Friendly Health Systems, an initiative of the John A. Hartford Foundation and Institute for Healthcare Improvement in partnership with the AHA and Catholic…